Search
Close this search box.
Search
Close this search box.

August 23, 2021

How to cast a smarter net

Taking a new approach to expert identification can reshape outcomes for life science teams.
KOL selection

For many pharmaceutical and medical device teams, KOL selection can go one of two ways: defaulting to the list of KOLs they always use or outsourcing the work to a third party. Problem is, there are drawbacks to both approaches. Going back to the same people over and over again lets you talk to the experts you know best – but they might not be the best people to provide insight on every topic or therapeutic area. And hiring a third party can be time-consuming and expensive.

Related Posts:

Medical science liaison guidelines

Medical science liaison guidelines

Event recap: Fierce Medical Affairs Strategic Summit

MSLs vs. medical affairs: how do they differ, and what are their roles?

More insights, direct to your inbox.